Sector Medical Research
Founders David Qixiang Chen, Elvis Wianda, Liran Belenzon, Tom Leung
Employees 251 – 500
Funding CAD $127.1M
Over the past century, human life expectancy across the globe has almost doubled, in large part due to medical discovery and innovation. More recently, scientific research toward life-prolonging cures and advances has become more expensive and time-consuming. Where some see challenge, BenchSci sees opportunity. The company leverages machine learning to help scientists facilitate – and accelerate – potentially ground-breaking research. BenchScian idea born of personal experience for founder Tom Leung, who remembers the frustration of trying to find antibodies for his experiments in epigenetics. It was, he recalls, a “tedious chore” – one that sometimes ended in heartbreak and the loss of valuable samples. Dr. Leung remembers thinking to himself: “What if I was to create a database that contains publication usage data for commercially available antibodies so that researchers can know what worked and what didn’t work, quickly and easily?” Today, BenchSci’s signature product – a reagent selection tool powered by biomedical AI – can be found in more than 4,500 research centers worldwide, including 16 of the top 20 pharma companies.